Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

Hair transplants can risk reactivating lichen planopilaris, a scarring hair loss condition.

Uterine leiomyomas don't significantly change gene expression in the scalp of people with Central Centrifugal Cicatricial Alopecia.

A rare skin condition called linear lichen planopilaris caused itchy red bumps and hair loss on a man's face.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

The guide helps dermatologists diagnose and treat different types of hair loss.

Hair transplant combining scalp and beard hair with PRP was successful for scarring alopecia.

Hair transplants for male baldness can show inflammation and fibrosis, but more research is needed to confirm LPP presence.

Dermoscopy is useful for diagnosing and monitoring discoid lupus erythematosus by showing specific skin patterns.

Understanding the cause of bitemporal hair loss is key to deciding the right treatment.

Biopsies matched initial diagnoses in 76.6% of black women with alopecia and led to treatment changes in 44% of cases.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

Alopecia areata can look like frontal fibrosing alopecia, making diagnosis hard.

Title change to "Central Centrifugal Cicatricial Alopecia (CCCA)"; common in African American women; hair-grooming methods may contribute; no effective therapy found; trials needed.

The document is a detailed guide on skin conditions and treatments for dermatologists.

PRP or nanofat injections improve scar tissue quality but don't significantly boost hair transplant results for scarring hair loss.

The document suggests simplifying alopecia diagnosis and improving techniques for better accuracy.

Dermoscopy is useful for diagnosing various skin, hair, and nail disorders and can reduce the need for biopsies.

The conclusion is that hair loss from CCCA may be genetic and not solely caused by hair grooming practices.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

Hair loss was the first sign of a brain-related complication in a woman with lupus, and early treatment helped her hair grow back.

The authors updated the criteria for diagnosing frontal fibrosing alopecia, making it easier to diagnose without a biopsy.

Damage to hair follicle stem cells causes permanent hair loss and scarring in cutaneous lupus erythematosus.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Wearing a high-quality wig improved a woman's mood and life quality, and the authors suggest insurance should cover the cost of wigs.

A woman with chronic hepatitis C had a rare skin condition linked to her illness.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Lichen planopilaris and frontal fibrosing alopecia are likely the same disease with different clinical appearances.

The article concludes that early treatment of alopecia is crucial to prevent permanent hair loss.